Physician profile
Anna Duong
NPI 1376014662
$4,350.49
in general payments reported to CMS, 2019-2025
17 companies · $928 in 2025
The $928 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $565 · 2022: $877 · 2023: $918 · 2024: $1,062 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,907.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,516.14 | 2021-2025 | |
| Revance Therapeutics, INC. | $622.56 | 2024-2025 | Daxxify |
| Merz North America, INC. | $429.11 | 2021-2024 | Xeomin |
| Lilly USA, LLC | $312.75 | 2021-2025 | Emgality, Kisunla, Amyvid |
| Upsher-Smith Laboratories LLC | $268.85 | 2021-2022 | |
| Pfizer INC. | $262.19 | 2023-2025 | |
| Lundbeck LLC | $244.03 | 2021-2025 | Vyepti |
| Galderma Laboratories, L.P. | $177.74 | 2021 | |
| Scilex Pharmaceuticals INC. | $107.41 | 2023-2024 | Ztlido |
| Impel Pharmaceuticals INC. | $73.62 | 2023 | Trudhesa |
| Impel Pharmaceuticals LLC | $60.72 | 2024 | Trudhesa |
| Teva Pharmaceuticals USA, INC. | $59.36 | 2023 | Austedo Xr, Ajovy |
| Amgen INC. | $54.60 | 2022 | |
| Axsome Therapeutics, INC. | $52.16 | 2025 | Symbravo |
| Amneal Pharmaceuticals LLC | $45.10 | 2021-2025 | Brekiya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $34.09 | 2022 | |
| Azurity Pharmaceuticals, INC. | $30.06 | 2023-2024 | Horizant, Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.